Women diagnosed with breast cancer face incredible obstacles and overcome overwhelming odds on their road to recovery. Among those obstacles is chemotherapy, which notoriously causes patients to lose their hair temporarily. What patients don’t know is that with one specific chemo drug – Taxotere – hair may never return.
In some women, Taxotere kills hair follicles with no way to reverse the damage, resulting in a lifetime of baldness. Even though Taxotere’s manufacturer knew about this for more than 20 years, it was kept from doctors and the public until just six months ago. Our Taxotere attorneys report on how the drugmaker got away with this deception and the stories of breast cancer survivors who now face a lifetime of alopecia.
Doctors started using Taxotere to treat breast cancer in 1996. Ten years later, an oncologist in Denver published the first study linking Taxotere to permanent hair loss. Dr. Sedlacek found that more than 6% of women treated with Taxotere experienced “persistent significant alopecia,” meaning permanent hair loss. Hair loss was especially common among women also treated with the drugs Taxotere with Adriamycin and Cyclophosphaamide.